The CKD3 summit is focused on tackling the challenges drug developers face in developing more efficacious therapeutics targeting Chronic Kidney Disease. Bringing together the leaders in this field to share the latest developments, insights and science that are reviving the field by demonstrating greater efficacy than the current standard of care.
IQVIA's Jula Inrig, Global Head Renal COE, will be speaking on day 1 of the summit. Her talk is titled: Optimizing Trial Planning & Implementation - the NextGen of Nephrology Trials. IQVIA will also have a booth at this summit.